← back to search

Ying Wan

Eon Corporation (United States) · CN
Area of research
Genetics · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Liver Disease Diagnosis and Treatment, and Hemoglobinopathies and Related Disorders.
h-index
40
citations
7,075
works
263
NIH funding
primary concept
Medicine
email

Recent publications

Stress-Driven Selective Neuronal Vulnerability in Charcot-Marie-Tooth Disease: From Prodromal Pathology to Therapeutic Implications.
2026cited by 0position: contributordoi
Ellagic Acid Ameliorates Ovarian Cancer via Modification of Pyroptosis and Inflammation
Iranian Journal of Allergy Asthma and Immunology 2025cited by 4position: lastdoi
Histone Modification Networks Reshape the Metabolism and Treatment Landscape of Urological Cancers.
2025cited by 0position: contributordoi
Capsule neural network and its applications in drug discovery.
2025cited by 0position: contributordoi
Trial Update from IMproveMF, an Ongoing, Open-Label, Dose-Escalation and -Expansion, Phase 1/1B Trial to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Novel Combination of Imetelstat with Ruxolitinib in Patients with Intermediate-1, Intermediate-2, or High-Risk Myelofibrosis (MF)
Blood 2024cited by 5position: middledoi
The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases
The American Journal of Pathology 2024cited by 4position: contributordoi
Dried <i>Zingiber officinale</i> Alleviates Dehydroepiandrosterone‐Induced Ovarian Granulosa Cell Apoptosis via the Reactive Oxygen Species‐Mediated Pathway
Journal of Food Biochemistry 2024cited by 0position: contributordoi
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2023cited by 128position: middledoi
miR-34a regulates macrophage-associated inflammation and angiogenesis in alcohol-induced liver injury.
2023cited by 23position: contributordoi
Up-regulation of the human-specific CHRFAM7A gene protects against renal fibrosis in mice with obstructive nephropathy.
2023cited by 6position: contributordoi
Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly
Medicine 2023cited by 5position: middledoi
Case report: Multiple biventricular aneurysms in arrhythmogenic cardiomyopathy
Frontiers in Cardiovascular Medicine 2023cited by 3position: middledoi
The GntR-like transcriptional regulator HutC involved in motility, biofilm-forming ability, and virulence in Vibrio parahaemolyticus
Microbial Pathogenesis 2022cited by 18position: middledoi
Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study
Blood 2022cited by 11position: middledoi
A Charcot-Marie-Tooth-Causing Mutation in HSPB1 Decreases Cell Adaptation to Repeated Stress by Disrupting Autophagic Clearance of Misfolded Proteins.
2022cited by 8position: contributordoi
Current Perspectives of Neuroendocrine Regulation in Liver Fibrosis.
2022cited by 6position: contributordoi
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis
Journal of Clinical Oncology 2021cited by 103position: middledoi
The relationship of severity in diastasis recti abdominis and pelvic floor dysfunction: a retrospective cohort study
BMC Women s Health 2021cited by 42position: middledoi
The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury
Journal of Biological Chemistry 2017cited by 76position: middledoi
The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals
Laboratory Investigation 2017cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2022–2026)Souria Dougherty · Gilead Sciences (United States)4 papers (2021–2024)Fanyin Meng · Beijing Computing Center4 papers (2017–2023)Faye Feller · Geron (United States)4 papers (2021–2024)Tymara Berry · Gilead Sciences (United States)3 papers (2022–2024)Rami S. Komrokji · Moffitt Cancer Center3 papers (2021–2023)Fei Huang · Gilead Sciences (United States)3 papers (2021–2024)Laurie Sherman · GAF (United States)3 papers (2021–2023)Uwe Platzbecker · University College London2 papers (2022–2023)Yazan F. Madanat · Southwestern Medical Center2 papers (2022–2023)Valeria Santini · University Hospital Leipzig2 papers (2022–2023)Nan Wu · Peking University2 papers (2017–2017)Libo Sun · Union Hospital2 papers (2022–2023) · 2 papers (2022–2023)Sheetal Shah · Gilead Sciences (United States)2 papers (2022–2023) · 2 papers (2023–2023)Pierre Fenaux · Hôpital Nord2 papers (2022–2023)Gianfranco Alpini · Richard L. Roudebush VA Medical Center2 papers (2017–2017)Shannon Glaser · Indiana University – Purdue University Indianapolis2 papers (2017–2017)Michael R. Savona · Vanderbilt University2 papers (2022–2023)